Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells

Journal of Clinical Investigation

Volumn 99, Issue 4, 1997, Pages 773-780

  Atger, Veronique M ^a   De La Llera Moya, Margarita ^b   Stoudt, Genevieve W ^b   Rodrigueza, Wendi V ^b   Phillips, Michael C ^b   Rothblat, George H ^b  

^a HÔPITAL BROUSSAIS   (France)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

cholesterol; cyclodextrins; foam cells; lipoproteins; serum

Indexed keywords

CHOLESTEROL; CYCLODEXTRIN DERIVATIVE; PHOSPHOLIPID;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL MEMBRANE TRANSPORT; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FOAM CELL; MOUSE; NONHUMAN; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL; TRANSPORT KINETICS;

EID: 1842287998     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119223     Document Type: Article

References (39)

1. Fielding, C.J., and P.E. Fielding. 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36:211-228.
2. Johnson, W.J., F.H. Mahlberg, G.H. Rothblat, and M.C Phillips. 1991. Cholesterol transport between cells and high density lipoproteins. Biochim. Biophys. Acta. 1085:273-298.
3. Rothblat, G.H., F.H. Mahlberg, W.J. Johnson, and M.C. Phillips. 1992. Apolipoprotein, membrane cholesterol domains, and the regulation of cholesterol efflux. J. Lipid Res. 33:1091-1098.
4. Oram, J.F. 1990. Cholesterol trafficking in cells. Curr. Opin. Lipidol. 1: 416-421.
5. Francone, O.L., and C.J. Fielding. 1990. Initial steps in reverse cholesterol transport: the role of short-lived cholesterol acceptors. Eur. Heart J. 11: 218-224.
6. de la Llera Moya, M., V. Atger, J.L. Paul, N. Fournier, N. Moatti, P. Giral, K.E. Friday, and G.H. Rothblat. 1994. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux: relationships between serum components and efflux, esterification and transfer. Arterioscler. Thromb. 14:1056-1065.
7. Pitha, J., T. Irie, P.B. Sklar, and J.S. Nye. 1988. Drug solubilizers to aid pharmacologists: amorphous cyclodextrin derivatives. Life Sci. 43:493-502.
8. Kilsdonk, E.P.C., P. Yancey, G. Stoudt, F.W. Bangerter, W.J. Johnson, M.C. Phillips, and G.H. Rothblat. 1995. Cellular cholesterol efflux mediated by cyclodextrins. J. Biol. Chem. 270:17250-17256.
9. Yancey, P.G., W.V. Rodrigueza, E.P.C. Kilsdonk, G.W. Stoudt, W.J. Johnson, M.C. Phillips, and G.H. Rothblat. 1996. Cellular cholesterol efflux mediated by cyclodextrins: demonstration of kinetic pools and mechanism of efflux. J. Biol. Chem. 271:16026-16034.
10. Rodrigueza, W.V., P.H. Pritchard, and M.J. Hope. 1993. The influence of size and composition of the cholesterol mobilizing properties of liposomes in vivo. Biochim. Biophys. Acta. 1153:9-19.
11. Davidson, W.S., W.V. Rodrigueza, S. Lund-Katz, W.J. Johnson, G.H. Rothblat, and M.C. Phillips. 1995. Effects of acceptor particle size on the efflux of cellular free cholesterol. J. Biol. Chem. 270:17106-17113.
12. Bernard, D.W., A. Rodriguez, G.H. Rothblat, and J.M. Glick. 1991. cAMP stimulates cholesteryl ester clearance to high density lipoproteins in J774 macrophages. J. Biol. Chem. 266:710-716.
13. Warner, G.J., G. Stoudt, M. Bamberger, W.J. Johnson, and G.H. Rothblat. 1995. Cell toxicity induced by inhibition of acyl coenzyme A cholesterol acyltransferase and accumulation of unesterified cholesterol. J. Biol. Chem. 270:5772-5778.
14. Ross, A.C., K. Go, J. Heider, and G.H. Rothblat. 1984. Selective inhibition of acylCoA:cholesterol acyltransferase by compound 58-035. J. Biol. Chem. 258:815-819.
15. Yancey, P.G., J.K. Bielicki, W.J. Johnson, S. Lund-Katz, M.N. Palgunachari, G.M. Anantharamaiah, J.P. Segrest, M.C. Phillips, and G.H. Rothblat. 1995. The efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry. 34:7955-7965.
16. Fedoroff, S. 1958. Effect of human blood serum on tissue cultures. I. Some properties and specificity of toxic human serum, and its interaction with strain L cells. Tex. Rep. Biol. Med. 16:31-47.
17. Fedoroff, S., and J. Doerr. 1962. Effect of human blood serum on tissue cultures. III. A natural cytotoxic system in human blood serum. J. Natl. Cancer Inst. 29:331-347.
18. Ishikawa, T.T., J. MacGee, J.A. Morrison, and C.J. Glueck. 1974. Quantitative analysis of cholesterol in 5 to 20 μl of plasma. J. Lipid Res. 15:286-291.
19. Klansek, J., P. Yancey, R.W. St. Clair, R.T. Fischer, W.J. Johnson, and J.M. Glick. 1995. Cholesterol quantitation by GLC: artifactual formation of short-chain steryl esters. J. Lipid Res. 36:2261-2266.
20. Markwell, M.A.K., S.M. Haas, L.L. Bieber, and N.E. Tolbert. 1978. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87:206-210.
21. Johnson, W.J., M.J. Bamberger, R.A. Latta, P.E. Rapp, M.C. Phillips, and G.H. Rothblat. 1986. The bidirectional flux of cholesterol between cells and lipoproteins. J. Biol. Chem. 261:5766-5776.
22. Bernard, D.W., A. Rodriguez, G.H. Rothblat, and J.M. Glick. 1990. Influence of high density lipoprotein on esterified cholesterol stores in macrophages and hepatoma cells. Arteriosclerosis. 10:135-144.
23. Johnson, W.J., F.H. Mahlberg, G.K. Chacko, M.C. Phillips, and G.H. Rothblat. 1988. The influence of cellular and lipoprotein cholesterol contents on the flux of cholesterol between fibroblasts and high density lipoprotein. J. Biol. Chem. 263:14099-14106.
24. Fournier, N., M. de la Liera Moya, B. Burkey, J. Swaney, J.J. Paterniti, N. Moatti, V. Atger, and G.H. Rothblat. 1996. The role of HDL phospholipids in efflux of cell cholesterol to whole serum: studies with human apo AI transgenic rats. J. Lipid Res. 37:1704-1711.
25. Sloop, C.H., L. Dory, and P.S. Roheim. 1987. Interstitial fluid lipoproteins. J. Lipid Res. 28:225-237.
26. Atger, V., M. de la Llera Moya, M. Bamberger, O. Francone, P. Casgrove, A. Tall, A. Walsh, N. Moatti, and G. Rothblat. 1995. Cholesterol efflux potential of sera from mice expressing human CETP and/or human apolipoprotein AI. J. Clin. Invest. 96:2613-2622.
27. Irie, T., K. Fukunaga, and J. Pitha. 1992. Hydroxypropylcyclodextrins in parenteral use. I: lipid dissolution and effects on lipid transfers in vitro. J. Pharm. Sci 81:521-523.
28. Rajewski, R.A., G. Traiger, J. Breshnahan, P. Jaberaboansari, V.J. Stella, and D.O. Thompson. 1995. Preliminary safety evaluation of parenterally administered sylfoalkyl ether β-cyclodextrin derivatives. J. Pharm. Sci 84:927-932.
29. Rodrigueza, W.V., K.J. Williams, G.H. Rothblat, and M.C. Phillips. 1997. Remodeling and shuttling: mechanisms for the synergistic effects between different acceptor particles in the mobilization of cellular cholesterol. Arterioscler. Thromb. Vasc. Biol. 17:383-393.
30. Castro, G.R., and C.J. Fielding. 1988. Early incorporation of cell-derived cholesterol into pre-β-migrating high-density lipoprotein. Biochemistry. 27:25-29.
31. Hara, H., and S. Yokoyama. 1992. Role of apolipoproteins in cholesterol efflux from macrophages to lipid microemulsion: proposal of a putative model for the pre-β high-density lipoprotein pathway. Biochemistry. 31:2040-2046.
32. Jonas, A., K. Bottum, N. Theret, P. Duchateau, and G. Castro. 1994. Transfer of cholesterol from Ob1771 cells or LDL to reconstituted, defined high density lipoproteins. J. Lipid Res 35:860-870.
33. Irie, T., K. Fukunaga, M.K. Garwood, T.O. Carpenter, and J. Pitha. 1992. Hydroxypropylcyclodextrins in parenteral use. II: effects on transport and disposition of lipids in rabbit and humans. J. Pharm. Sci. 81:524-528.
34. Miyazaki, A., S. Sakuma, W. Morikawa, T. Takiue, F. Miake, T. Terano, M. Sakai, H. Hakamata, Y. Sakamoto, M. Naito, et al. 1995. Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits. Arterioscler. Thromb. Vasc. Biol. 15:1882-1888.
35. Sirtori, C.R. 1995. Recombinant apolipoproteins come of age. Nutr. Metab. Cardiovasc. Dis. 5:81-83.
36. Carlson, L.A. 1995. Effect of a single infusion of recombinant human proapolipoprotein A-I liposomes (synthetic HDL) on plasma lipoproteins in patients with low high density lipoprotein cholesterol. Nutr. Metab. Cardiovasc. Dis. 5:85-91.
37. Badimon, J.J., L. Badimon, A. Galvez, R. Dische, and V. Fuster. 1989. High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. Lab. Invest. 60:455-461.
38. Brown, B.G., X. Zhao, D.E. Sacco, and J.J. Albers. 1993. Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease. Circulation. 87:1781-1791.
39. Diederich, F., and B. Peterson. 1994. Dissolution of cholesterol in water by a synthetic receptor. Angew. Chemie. Int. Ed. Engl. 33:1625.